Donald Trump's FDA sent warning letters claiming chest binders are misbranded medical devices, raising concerns about restrictions on gender-affirming products and trans youth care.
Trump's FDA sends warning letters to companies selling chest binders
FDA sent warning letters to eleven chest binder sellers, asserting misbranding and requiring Class I device registration amid a broader crackdown on gender-affirming care.